Presidio Partners 2007 (Parallel), L.P.
CIK 0001405972 Name as filed on the most recent filing
Filed as Presidio Partners 2007 (Parallel), L.P. (3)· Cmea Ventures VII (Parallel) LP (28)
103 transaction lines · from 31 filings · filed 2014-02-12 to 2018-07-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Menlo Therapeutics Inc. 1 filings
- ISSUER Neos Therapeutics, Inc. 2 filings
- ISSUER Auspex Pharmaceuticals, Inc. 25 filings
- ISSUER Ardelyx, Inc. 3 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2018-07-24 |
Menlo Therapeutics Inc. MNLO |
S, Open-market sale | 487,500 disposed | 7.65 | 3,729,375.00 | Form 4, filing 0001144204-18-040247 | |
| 2018-07-24 |
Menlo Therapeutics Inc. MNLO |
S, Open-market sale | 12,500 disposed | 7.65 | 95,625.00 | Form 4, filing 0001144204-18-040247 | |
| 2016-04-20 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 8,327 disposed | 9.88 | 82,304.90 | Form 4, filing 0001209191-16-115074 | |
| 2016-04-20 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 213 disposed | 9.88 | 2,105.31 | Form 4, filing 0001209191-16-115074 | |
| 2016-04-19 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 7,097 disposed | 10.03 | 71,175.81 | Form 4, filing 0001209191-16-115074 | |
| 2016-04-19 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 182 disposed | 10.03 | 1,825.28 | Form 4, filing 0001209191-16-115074 | |
| 2016-04-18 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 4,434 disposed | 10.10 | 44,781.63 | Form 4, filing 0001209191-16-115074 | |
| 2016-04-18 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 114 disposed | 10.10 | 1,151.35 | Form 4, filing 0001209191-16-115074 | |
| 2016-04-15 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 10,735 disposed | 10.13 | 108,697.24 | Form 4, filing 0001209191-16-114436 | |
| 2016-04-15 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 7,020 disposed | 10.32 | 72,429.55 | Form 4, filing 0001209191-16-114436 | |
| 2016-04-15 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 275 disposed | 10.13 | 2,784.51 | Form 4, filing 0001209191-16-114436 | |
| 2016-04-15 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 180 disposed | 10.32 | 1,857.17 | Form 4, filing 0001209191-16-114436 | |
| 2016-04-14 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 13,714 disposed | 10.27 | 140,794.78 | Form 4, filing 0001209191-16-114436 | |
| 2016-04-14 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 12,675 disposed | 10.32 | 130,783.18 | Form 4, filing 0001209191-16-114436 | |
| 2016-04-14 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 352 disposed | 10.27 | 3,613.81 | Form 4, filing 0001209191-16-114436 | |
| 2016-04-14 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 325 disposed | 10.32 | 3,353.42 | Form 4, filing 0001209191-16-114436 | |
| 2016-04-13 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 12,375 disposed | 10.16 | 125,753.51 | Form 4, filing 0001209191-16-114436 | |
| 2016-04-13 |
Neos Therapeutics, Inc. NEOS |
S, Open-market sale | 317 disposed | 10.16 | 3,221.32 | Form 4, filing 0001209191-16-114436 | |
| 2015-02-13 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 40,786 disposed | 62.98 | 2,568,824.64 | Form 4, filing 0001209191-15-014665 | |
| 2015-02-13 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 1,047 disposed | 62.98 | 65,943.20 | Form 4, filing 0001209191-15-014665 | |
| 2015-02-12 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 66,138 disposed | 62.96 | 4,164,127.85 | Form 4, filing 0001209191-15-014665 | |
| 2015-02-12 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 12,675 disposed | 64.00 | 811,200.00 | Form 4, filing 0001209191-15-014665 | |
| 2015-02-12 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 1,696 disposed | 62.96 | 106,782.20 | Form 4, filing 0001209191-15-014665 | |
| 2015-02-12 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 325 disposed | 64.00 | 20,800.00 | Form 4, filing 0001209191-15-014665 | |
| 2015-02-11 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 51,773 disposed | 61.84 | 3,201,642.32 | Form 4, filing 0001209191-15-014662 | |
| 2015-02-11 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 1,327 disposed | 61.84 | 82,061.68 | Form 4, filing 0001209191-15-014662 | |
| 2015-02-11 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 51,773 disposed | 61.84 | 3,201,642.32 | Form 4, filing 0001209191-15-012032 | |
| 2015-02-11 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 1,327 disposed | 61.84 | 82,061.68 | Form 4, filing 0001209191-15-012032 | |
| 2015-02-10 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 20,670 disposed | 60.05 | 1,241,233.50 | Form 4, filing 0001209191-15-014662 | |
| 2015-02-10 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 20,670 disposed | 60.05 | 1,241,233.50 | Form 4, filing 0001209191-15-012032 | |
| 2015-02-10 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 530 disposed | 60.05 | 31,826.50 | Form 4, filing 0001209191-15-012032 | |
| 2015-02-09 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 9,608 disposed | 59.00 | 566,872.00 | Form 4, filing 0001209191-15-012032 | |
| 2015-02-09 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 246 disposed | 59.00 | 14,514.00 | Form 4, filing 0001209191-15-012032 | |
| 2015-02-06 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 29,522 disposed | 59.48 | 1,755,968.56 | Form 4, filing 0001209191-15-010389 | |
| 2015-02-06 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 757 disposed | 59.48 | 45,026.36 | Form 4, filing 0001209191-15-010389 | |
| 2015-02-05 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 12,578 disposed | 59.51 | 748,516.78 | Form 4, filing 0001209191-15-010389 | |
| 2015-02-05 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 322 disposed | 59.51 | 19,162.22 | Form 4, filing 0001209191-15-010389 | |
| 2015-02-04 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 48,750 disposed | 59.30 | 2,890,875.00 | Form 4, filing 0001209191-15-010389 | |
| 2015-02-04 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 1,250 disposed | 59.30 | 74,125.00 | Form 4, filing 0001209191-15-010389 | |
| 2015-01-30 |
Ardelyx, Inc. ARDX |
S, Open-market sale | 165,750 disposed | 27.37 | 4,536,577.50 | Form 4, filing 0001209191-15-008985 | |
| 2015-01-30 |
Ardelyx, Inc. ARDX |
S, Open-market sale | 4,250 disposed | 27.37 | 116,322.50 | Form 4, filing 0001209191-15-008985 | |
| 2015-01-08 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 3,260 disposed | 49.13 | 160,160.54 | Form 4, filing 0001209191-15-014657 | |
| 2015-01-08 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 84 disposed | 49.13 | 4,126.84 | Form 4, filing 0001209191-15-014657 | |
| 2015-01-08 |
Ardelyx, Inc. ARDX |
S, Open-market sale | 292,500 disposed | 24.25 | 7,093,125.00 | Form 4, filing 0001209191-15-003754 | |
| 2015-01-08 |
Ardelyx, Inc. ARDX |
S, Open-market sale | 7,500 disposed | 24.25 | 181,875.00 | Form 4, filing 0001209191-15-003754 | |
| 2014-12-18 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 190,125 disposed | 50.14 | 9,532,867.50 | Form 4, filing 0001209191-14-077452 | |
| 2014-12-18 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 4,875 disposed | 50.14 | 244,432.50 | Form 4, filing 0001209191-14-077452 | |
| 2014-10-30 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 7,633 disposed | 27.33 | 208,582.41 | Form 4, filing 0001209191-14-065571 | |
| 2014-10-30 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 197 disposed | 27.33 | 5,383.30 | Form 4, filing 0001209191-14-065571 | |
| 2014-10-29 |
Auspex Pharmaceuticals, Inc. ASPX |
S, Open-market sale | 10,891 disposed | 27.02 | 294,307.49 | Form 4, filing 0001209191-14-065571 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Presidio Partners 2007 (Parallel), L.P., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001405972
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6